News

Hosted on MSN9mon
Trinity Biotech's Stock Rises After Acquisition of Metabolomics - MSN
Trinity Biotech will pay the amount with just over 270,000 Trinity Biotech plc’s American Depositary Shares and the rest in cash and assumption of liabilities.
Hosted on MSN8mon
Trinity Biotech Shares Surge on Positive Pre-Pivotal Clinical CGM Trial - MSN
Trinity Biotech plc TRIB has completed its first pre-pivotal clinical trial in Europe for its next-generation continuous glucose monitor (CGM). This trial assessed the effectiveness of significant ...
Nasdaq5mon
Trinity Biotech Announces Promising Pre-Pivotal Trial Results for Next-Generation Continuous Glucose Monitoring System - Nasdaq
Trinity Biotech plc has announced encouraging results from its recent pre-pivotal clinical trial of its next-generation continuous glucose monitoring (CGM) system, targeting diabetes management.
Yahoo Finance5mon
Trinity Biotech Announces Breakthrough Results From Pre-Pivotal Trial of Disruptive Continuous Glucose Monitoring (CGM) Technology - Yahoo Finance
Trinity Biotech’s patented technology represents a paradigm shift in the global CGM market, projected to exceed $20 billion by 2029DUBLIN, Ireland, Jan. 28, 2025 (GLOBE NEWSWIRE) -- Trinity ...
Nasdaq4mon
Trinity Biotech Secures Additional $4 Million in Debt Financing to Advance Continuous Glucose Monitoring Technology and Transformation Plan - Nasdaq
Trinity Biotech plc, a biotechnology company specializing in human diagnostics and diabetes management, announced it has secured an additional $4 million in debt financing from Perceptive Advisors.
Yahoo Finance8mon
Trinity Biotech Announces Positive Pre-Pivotal Trial Results for Its Next-Generation Continuous Glucose Monitor Technology - Yahoo Finance
Trinity Biotech’s Chief Technology Officer, Dr Gary Keating, added, “Our next phase of refinements, guided by this study’s positive results, will be tested in a second European pre-pivotal ...
WNCT6mon
Trinity Biotech Receives Early Approval from the World Health Organization to Begin Offshore Manufacturing of TrinScreen HIV & Uni-Gold HIV
DUBLIN, Ireland, Dec. 18, 2024 (GLOBE NEWSWIRE) -- Trinity Biotech plc (Nasdaq: TRIB), a commercial-stage biotechnology company focused on human diagnostics and diabetes management solutions ...
Seeking Alpha3mon
Trinity Biotech Further Strengthens Focus on Continuous Glucose Monitoring – Appoints Barclays to Advise on Ongoing Strategic Realignment Process - Seeking Alpha
DUBLIN and PORTLAND, Ore., March 13, 2025 (GLOBE NEWSWIRE) -- Trinity Biotech plc (TRIB), a commercial-stage biotechnology company focused on human diagnostics and diabetes management solutions ...
Seeking Alpha1y
Trinity Biotech plc (TRIB) Q1 2024 Earnings Call Transcript
Trinity Biotech plc (NASDAQ:TRIB) Q1 2024 Results Conference Call May 23, 2024 8:30 AM ETCompany Participants. Eric Ribner - Investor Relations John Gillard - Chief Executive Officer Des ...
MarketWatch21y
Biotech stocks higher, led by Trinity Biotech - MarketWatch
BOSTON (CBS.MW) -- Biotechnology stocks were edging higher in early trading Monday with shares of Trinity Biotech soaring after the Irish company said it won U.S. clearance for its 10-minute HIV ...
Business Insider8mon
Trinity Biotech Announces Positive Pre-Pivotal Trial Results for Its Next-Generation Continuous Glucose Monitor Technology - Markets Insider
Trinity Biotech’s Chief Technology Officer, Dr Gary Keating, added, “Our next phase of refinements, guided by this study’s positive results, will be tested in a second European pre-pivotal ...